Officers of the CDC’s Epidemic Intelligence Service (EIS) presented recent research on tuberculosis (TB) on May 3 in a session at the 65th Annual Epidemic Intelligence Service Conference in Atlanta, Georgia. A summary of the presentations is included in this article.
Evidence from a clinical trial has shown that a new vaccine protects adults against malaria infection for at least 14 months.
Contagion™ Editorial Board member, Charitha Gowda, MD, MPH breaks down the World Health Organization hepatitis C (HCV) guidelines update, and reminds healthcare professionals to build on these guidelines to advocate for the most effective and safest treatment options for our individual patients and all patients worldwide.
Older antibiotic agents show decreased potency due to overuse and the subsequent emergence of drug-resistant bacteria. This antimicrobial resistance has been predicted to have enormous consequences for human health, necessitating the development of new agents in the ongoing war between humans and the germs that attack us.
Public health leaders have serious concerns about influenza, according to Dan Jernigan, MD, MPH, director of the Centers for Disease Control and Prevention (CDC) Influenza Division during a session on influenza on May 2nd during the 65th Annual Epidemic Intelligence Service (EIS) Conference in Atlanta, Georgia.
To inform Puerto Rico residents of the threat of the Zika virus, the National Association of Chain Drug Stores (NACDS) Foundation has launched a digital Zika education campaign.
The Centers for Disease Control and Prevention (CDC) just released updated guidance for Zika diagnostic testing.
Margaret Honein, MPH, PhD, chief of Centers for Disease Control and Prevention (CDC)’s Birth Defects Branch in the National Center on Birth Defects and Developmental Disabilities updated health professionals at a special session on Zika virus infection during the 65th Annual EIS Conference in Atlanta, Georgia.
An ongoing malaria outbreak in Colombia has been linked to illegal mining practices in the South American country.
Is the U.S. a Pandora's box of laboratory biosafety failures?
Executives at Dole Food Co. Inc. knew about an outbreak of Listeria at the company’s salad production plant in Springfield, Ohio for more than a year before shutting it down in January.
Officials are stating that although the first case of locally-acquired Zika virus in the United States may be weeks or months away, the time to prepare is now.
Antibiotic-resistant pathogens continue to make the management of some bacterial infections a significant clinical challenge.
In an effort to aid in the prevention of food-borne infections, the USDA created a mobile app that provides users with “valuable storage advice” to help maximize shelf-life, prolong freshness, and improve the quality of foods and beverages.
Researchers have found a potential solution for the troubling spread of Zika virus in Brazil and across the Southern hemisphere—and it’s bacteria.
In a recent study, researchers explore and discuss the development and implementation of a new insecticide resistance management plan in Zambia between 2009 and 2014.
As the Centers for Disease Control and Prevention (CDC) learns more about the threat of Zika virus infection on pregnant women and their growing fetuses, it will continue to share its knowledge with researchers, healthcare providers and the public.
The Ministry of Health (MOH) of Brazil has confirmed 1,271 nationwide cases of microcephaly.
Researchers at the University of North Carolina-Chapel Hill have identified what they describe as a new, “SARS-like” virus that will not need to adapt in order to infect humans.
Turtles are one of the many pets that can infect people with Salmonella; they have been linked to four 2015 multistate outbreaks in the United States.
Recent data from Bahia State, Brazil, show that Zika virus infection during the first trimester of pregnancy, or early in the second trimester, is associated with the observed increase in infants born with microcephaly.
The results of a methylome-wide analysis of human immunodeficiency virus (HIV) chronically infected, combination anti-retroviral therapy (cART)-treated individuals recently published in Molecular Cell suggest that HIV+ individuals have an epigenetic age 4.9 years older than healthy controls, resulting in an expected total mortality risk increase of 19%.
It is hoped that this proof of concept research may lead to promising new drug candidates to combat hPIV-3, which is the principal cause of acute respiratory illness in infants.
Consumers should note that the recalled products may have been purchased in all fifty US states and select provinces in Canada: British Colombia, Alberta, Manitoba, and Saskatchewan.
The ongoing refugee crisis facing European countries as a result of conflicts in the Middle East presents a potential public health challenge to governments already struggling with the influx of hundreds of new migrants on a daily basis.
Zika, Dengue, Chikungunya. These are the most recent viruses causing outbreaks in several regions of the world, all spread through the bite of an infected female Aedes aegypti mosquito. There is currently no cure for these viruses, which makes infection prevention a priority.
A recent review article on the status of influenza vaccines, their short-comings, and ways to improve them suggests the potential for significant improvements in the performance of future influenza vaccines.
Adding to the troubling data worldwide on antibiotic resistance, researchers have found that even trace concentrations of antibiotics, such as those found in sewage, are sufficient for bacteria to maintain resistance to most broad-spectrum agents.
In a one-arm study examined by the German Institute for Quality and Efficiency in Health Care (IQWiG), the added benefit of rilpivirine for HIV-positive children and adolescents between the ages of 12 and 18, was not proven, contrary to the belief of the manufacturer.
Puerto Rico, one of the countries currently experiencing active Zika virus transmission, has reported its first Zika-related death.
